Parallax Volatility Advisers
AVEO

Parallax Volatility Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Parallax Volatility Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,300
Closed -$48K – 3669
2021
Q2 		$48K Buy
+7,300
New +$50.3K ﹤0.01% 2657

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Parallax Volatility Advisers's AVEO Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2021, closing a stake of 7,300 shares — an estimated $48K sold.

Parallax Volatility Advisers first reported a position in AVEO in Q4 2018 and held it in 3 quarters. The position peaked at $48K in Q2 2021. 52 funds tracked by Wall St. Rank hold AVEO as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,300 AVEO Pharmaceuticals, Inc. shares in Q3 2021, an estimated $48K.
  • Parallax Volatility Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 3 quarters.
  • Parallax Volatility Advisers's AVEO Pharmaceuticals, Inc. position peaked at $48K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.